Archford Capital Strategies »

Halozyme Therapeutics shares owned by Archford Capital Strategies

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Archford Capital Strategies from 13F filings

Historical chart of Archford Capital Strategies investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Archford Capital Strategies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Archford Capital Strategies

Quarter filed Position value Share count Share price at filing
2025-09-30 $298k 4.1k 73.34